MORGAN STANLEY - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$906,222
-47.5%
1,022,825
-6.9%
0.00%
Q3 2022$1,725,000
-71.1%
1,098,967
-63.0%
0.00%
-100.0%
Q2 2022$5,972,000
-21.9%
2,972,031
-9.4%
0.00%0.0%
Q1 2022$7,645,000
+80.0%
3,281,214
+259.2%
0.00%0.0%
Q4 2021$4,247,000
-35.4%
913,501
+6.1%
0.00%0.0%
Q3 2021$6,572,000
-25.7%
861,269
-5.7%
0.00%0.0%
Q2 2021$8,851,000
+32.8%
913,309
+13.3%
0.00%0.0%
Q1 2021$6,667,000
-49.8%
805,985
-58.6%
0.00%
-50.0%
Q4 2020$13,294,000
-56.5%
1,947,893
-29.0%
0.00%
-66.7%
Q3 2020$30,580,000
+444.7%
2,742,494
+206.8%
0.01%
+500.0%
Q2 2020$5,614,000
+2330.3%
893,876
+606.9%
0.00%
Q1 2020$231,000
-74.1%
126,456
-52.1%
0.00%
Q4 2019$892,000
+350.5%
263,854
+183.4%
0.00%
Q3 2019$198,000
+61.0%
93,106
+103.1%
0.00%
Q2 2019$123,000
-81.2%
45,841
-66.7%
0.00%
Q1 2019$654,000
-87.6%
137,606
-93.7%
0.00%
-100.0%
Q4 2018$5,258,000
+303.8%
2,190,901
+639.9%
0.00%
Q3 2018$1,302,000
-60.6%
296,088
-35.5%
0.00%
-100.0%
Q2 2018$3,303,000
+494.1%
458,802
+324.7%
0.00%
Q1 2018$556,000
+1058.3%
108,023
+744.6%
0.00%
Q4 2017$48,000
+433.3%
12,790
+124.9%
0.00%
Q3 2017$9,000
-89.7%
5,687
-86.9%
0.00%
Q2 2017$87,000
-74.7%
43,506
-50.0%
0.00%
Q1 2017$344,000
-67.4%
86,970
-59.6%
0.00%
Q4 2016$1,056,000
+670.8%
215,486
+1118.4%
0.00%
Q3 2016$137,000
+114.1%
17,686
+54.1%
0.00%
Q2 2016$64,000
-20.0%
11,480
-22.2%
0.00%
Q1 2016$80,000
-69.0%
14,755
-50.2%
0.00%
Q4 2015$258,000
+106.4%
29,632
+98.8%
0.00%
Q3 2015$125,000
-95.2%
14,907
-90.0%
0.00%
-100.0%
Q2 2015$2,616,000
+1.6%
148,429
-33.4%
0.00%0.0%
Q1 2015$2,576,000
+117.6%
222,804
+89.4%
0.00%
Q4 2014$1,184,000
+11740.0%
117,645
+7743.0%
0.00%
Q2 2014$10,000
+42.9%
1,500
+160.9%
0.00%
Q1 2014$7,0005750.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders